scholarly journals Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services

PLoS ONE ◽  
2019 ◽  
Vol 14 (11) ◽  
pp. e0225460 ◽  
Author(s):  
Kinna Thakarar ◽  
Kristina E. Rokas ◽  
F. L. Lucas ◽  
Spencer Powers ◽  
Elizabeth Andrews ◽  
...  
2015 ◽  
Vol 156 ◽  
pp. e111-e112
Author(s):  
Theresa W. Kim ◽  
Judith Bernstein ◽  
Debbie M. Cheng ◽  
Jeffrey Samet ◽  
Christine Lloyd-Travaglini ◽  
...  

2020 ◽  
pp. 104973232097123
Author(s):  
Barbara Andraka-Christou ◽  
Olivia Randall-Kosich ◽  
Rachel Totaram

Treatment preferences of people with opioid use disorder (OUD) have been underexplored, especially among those with a history of utilizing medications for opioid use disorder (MOUD). Therefore, we sought to understand preferred characteristics of substance use disorder treatment centers among people recovering from OUD with a history of MOUD utilization. We recruited 30 individuals from eight states through snowball sampling initiated at three syringe exchange programs. Telephone interviews were audio-recorded and transcribed in 2018–2019. Inductive thematic analysis in Dedoose software occurred iteratively with recruitment. The following were “ideal” treatment center themes: a menu of treatment options, including MOUD and nonspiritual peer support groups; an integrated system with multiple care levels (e.g., outpatient, residential); a harm reduction approach, including for goal setting and success measures; adjunctive support services (e.g., housing); and employees with recovery experience and professional education. Many preferences directly related to core principles of person-centered care and harm reduction.


2020 ◽  
Vol 14 (6) ◽  
pp. e350-e354
Author(s):  
Max Jordan Nguemeni Tiako ◽  
Seong Hong ◽  
Syed Usman Bin Mahmood ◽  
Makoto Mori ◽  
Abeel Mangi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document